MedPath

ZURZUVAE

These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE (zuranolone) capsules, for oral use, CIVInitial U.S. Approval: 2023

Approved
Approval ID

f18e53b0-d0bb-422d-8de7-ab64b7292b29

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2023

Manufacturers
FDA

Biogen MA Inc.

DUNS: 121376230

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

zuranolone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64406-029
Application NumberNDA217369
Product Classification
M
Marketing Category
C73594
G
Generic Name
zuranolone
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 29, 2023
FDA Product Classification

INGREDIENTS (6)

ZURANOLONEActive
Quantity: 20 mg in 1 1
Code: 7ZW49N180B
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Quantity: 26.19 mg in 1 1
Code: OP1R32D61U
Classification: IACT
MANNITOLInactive
Quantity: 105.92 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
SILICON DIOXIDEInactive
Quantity: 1.667 mg in 1 1
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Quantity: 10.002 mg in 1 1
Code: M28OL1HH48
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Quantity: 2.9175 mg in 1 1
Code: 7CV7WJK4UI
Classification: IACT

zuranolone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64406-031
Application NumberNDA217369
Product Classification
M
Marketing Category
C73594
G
Generic Name
zuranolone
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 29, 2023
FDA Product Classification

INGREDIENTS (6)

MICROCRYSTALLINE CELLULOSEInactive
Quantity: 39.28 mg in 1 1
Code: OP1R32D61U
Classification: IACT
MANNITOLInactive
Quantity: 158.85 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
ZURANOLONEActive
Quantity: 30 mg in 1 1
Code: 7ZW49N180B
Classification: ACTIM
SILICON DIOXIDEInactive
Quantity: 2.5 mg in 1 1
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Quantity: 15 mg in 1 1
Code: M28OL1HH48
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Quantity: 4.375 mg in 1 1
Code: 7CV7WJK4UI
Classification: IACT

zuranolone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64406-030
Application NumberNDA217369
Product Classification
M
Marketing Category
C73594
G
Generic Name
zuranolone
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 29, 2023
FDA Product Classification

INGREDIENTS (6)

ZURANOLONEActive
Quantity: 25 mg in 1 1
Code: 7ZW49N180B
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Quantity: 32.72 mg in 1 1
Code: OP1R32D61U
Classification: IACT
MANNITOLInactive
Quantity: 132.35 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
SILICON DIOXIDEInactive
Quantity: 2.084 mg in 1 1
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Quantity: 12.503 mg in 1 1
Code: M28OL1HH48
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Quantity: 3.646 mg in 1 1
Code: 7CV7WJK4UI
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZURZUVAE - FDA Drug Approval Details